Novateor Research Laboratories
Close ·
- P/E
- Not meaningful: loss-making over the last twelve months
Key Fundamentals
SMEPersonal ProductsFMCGPrice-based figures at the close · TTM
- ROCE
- 1.67%
- Debt to Equity
- 0.09
- EPS (TTM)
- ₹0.00
- Book Value
- ₹18.51
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 2.32
- ROE
- 0.91%
- Dividend Yield
- 0.00%
- EBITDA
- ₹40.00 L
- 52W High
- ₹43.00
- 52W Low
- ₹20.08
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 0.72% over last 3 years.
- Company has high debtors of 269 days.
- Promoter holding has decreased over last 3 years: -10.1%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 3 | 12 |
| Oscillators | Bearish | 4 | 3 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 63.87
- Neutral
- MACD (12,26,9)
- 1.66
- Bullish
- SMA (50)
- 34.83
- Bullish
- SMA (200)
- 28.97
- Bullish
As of , the latest day with price data, so these readings are not current.
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 10Y | +43.99% |
|---|---|
| 5Y | +82.34% |
| 3Y | +44.86% |
| 1Y | +37.77% |
Net profit
| 10Y | Zero base |
|---|---|
| 5Y | +58.49% |
| 3Y | +35.72% |
| 1Y | +25.00% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Outflow narrowed by ₹0.09 Cr |
| 3Y | Outflow narrowed by ₹0.79 Cr |
| 1Y | Outflow narrowed by ₹0.85 Cr |
Operating margin· change in pp
| 10Y | +7.39 pp |
|---|---|
| 5Y | +171.07 pp |
| 3Y | +24.37 pp |
| 1Y | +2.43 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2017 | ₹0.14 Cr |
|---|---|
| Mar 2018 | ₹0.09 Cr |
| Mar 2019 | ₹0.41 Cr |
| Mar 2020 | ₹0.39 Cr |
| Mar 2021 | ₹0.19 Cr |
| Mar 2022 | ₹0.74 Cr |
| Mar 2023 | ₹1.26 Cr |
| Mar 2024 | ₹1.21 Cr |
| Mar 2025 | ₹2.78 Cr |
| Mar 2026 | ₹3.83 Cr |
Net profit by year
| Mar 2017 | ₹0.00 Cr |
|---|---|
| Mar 2018 | ₹0.00 Cr |
| Mar 2019 | ₹0.22 Cr |
| Mar 2020 | −₹0.01 Cr |
| Mar 2021 | ₹0.01 Cr |
| Mar 2022 | −₹0.23 Cr |
| Mar 2023 | ₹0.04 Cr |
| Mar 2024 | ₹0.03 Cr |
| Mar 2025 | ₹0.08 Cr |
| Mar 2026 | ₹0.10 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.07 | 0.12 | 0.28 | 0.46 | 0.82 | 0.44 | 0.36 | 0.85 | 0.79 | 1.98 | 2.47 | 1.36 |
| Expenses | 0.16 | 0.36 | 0.35 | 0.57 | 1.01 | 0.58 | 0.53 | 1 | 0.9 | 2 | 2.59 | 1.35 |
| Operating Profit | −0.09 | −0.24 | −0.07 | −0.11 | −0.19 | −0.14 | −0.17 | −0.15 | −0.11 | −0.02 | −0.12 | 0.01 |
| OPM % | −128.57% | −200% | −25% | −23.91% | −23.17% | −31.82% | −47.22% | −17.65% | −13.92% | −1.01% | −4.86% | 0.74% |
| Other Income | 0 | 0.44 | −0.21 | 0.22 | 0.24 | 0.25 | 0.24 | 0.24 | 0.24 | 0.24 | 0.25 | 0.24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.02 | 0.01 | 0.02 | 0.05 | 0.05 | 0.04 |
| Depreciation | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.06 | 0.1 | 0.09 | 0.09 |
| PBT | −0.14 | 0.15 | −0.33 | 0.07 | 0.01 | 0.04 | 0.01 | 0.04 | 0.05 | 0.07 | −0.01 | 0.12 |
| Tax % | 0% | 0% | 0% | −42.86% | 0% | 0% | 0% | 0% | 20% | 28.57% | 100% | 8.33% |
| Net Profit | −0.13 | 0.15 | −0.33 | 0.1 | 0.01 | 0.03 | 0.01 | 0.04 | 0.03 | 0.05 | −0.02 | 0.12 |
| EPS (₹) | −0.27 | 0.31 | −0.68 | 0.21 | 0.02 | 0.06 | 0.02 | 0.08 | 0.06 | 0.1 | −0.03 | 0.2 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0.1 | 0.14 | 0.09 | 0.41 | 0.39 | 0.19 | 0.74 | 1.26 | 1.21 | 2.78 | 3.83 |
| Expenses | 0.02 | 0.11 | 0.08 | 0.04 | 0.13 | 0.53 | 0.52 | 0.92 | 1.6 | 1.54 | 2.92 | 3.93 |
| Operating Profit | 0 | −0.01 | 0.06 | 0.05 | 0.28 | −0.14 | −0.33 | −0.18 | −0.34 | −0.33 | −0.14 | −0.1 |
| OPM % | 0% | −10% | 42.86% | 55.56% | 68.29% | −35.9% | −173.68% | −24.32% | −26.98% | −27.27% | −5.04% | −2.61% |
| Other Income | 0 | 0.01 | 0.02 | 0.03 | 0.11 | 0.27 | 0.44 | 0.01 | 0.49 | 0.49 | 0.48 | 0.49 |
| Interest | 0 | 0 | 0.01 | 0.01 | 0 | 0.01 | 0 | 0 | 0.02 | 0.03 | 0.07 | 0.09 |
| Depreciation | 0 | 0 | 0.07 | 0.07 | 0.1 | 0.1 | 0.1 | 0.09 | 0.09 | 0.08 | 0.16 | 0.19 |
| PBT | 0 | 0 | 0 | 0 | 0.29 | 0.02 | 0.01 | −0.26 | 0.04 | 0.05 | 0.11 | 0.11 |
| Tax % | — | — | — | — | 24.14% | 150% | 0% | −11.54% | 0% | 40% | 27.27% | 18.18% |
| Net Profit | 0 | 0 | 0 | 0 | 0.22 | −0.01 | 0.01 | −0.23 | 0.04 | 0.03 | 0.08 | 0.1 |
| EPS (₹) | 0 | 0 | 0 | 0 | 0.74 | −0.02 | 0.02 | −0.48 | 0.08 | 0.06 | 0.17 | 0.17 |
| Div. Payout % | — | — | — | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 0.05 | 0.05 | 2.96 | 4.83 | 4.83 | 4.83 | 4.83 | 4.83 | 4.83 | 6.05 |
| Reserves | 0.88 | 0.88 | 0.88 | 0.88 | 1.11 | 3.73 | 3.74 | 3.01 | 3.04 | 3.93 | 5.71 | 5.45 |
| Borrowings | 0.75 | 0.76 | 0.87 | 0.82 | 0.01 | 0 | 0.24 | 0.24 | 0.84 | 1.11 | 0.91 | 1.03 |
| Other Liabilities | 0.11 | 0.15 | 0.1 | 0.09 | 0.24 | 0.23 | 0.17 | 0.06 | 0.24 | 0.59 | 1.16 | 1.74 |
| Total Liabilities | 1.79 | 1.84 | 1.9 | 1.84 | 4.32 | 8.79 | 8.98 | 8.14 | 8.95 | 10.46 | 12.61 | 14.27 |
| Fixed Assets | 1.59 | 1.64 | 1.66 | 1.59 | 3.55 | 3.45 | 3.36 | 1.94 | 1.78 | 2.43 | 3.41 | 3.24 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.43 | 0.44 | 0 | 0 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 0.19 | 0.19 | 0.23 | 0.24 | 0.76 | 5.33 | 5.61 | 6.19 | 6.73 | 7.58 | 9.19 | 11.02 |
| Total Assets | 1.79 | 1.84 | 1.9 | 1.84 | 4.32 | 8.79 | 8.98 | 8.14 | 8.95 | 10.46 | 12.61 | 14.27 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | 0 | 0.01 | 0.05 | −0.07 | −3.42 | −0.27 | −0.97 | −0.97 | −0.98 | −1.03 | −0.18 |
| Investing | 0 | 0 | −0.01 | 0 | −1.96 | −0.1 | −0.09 | 0.91 | 0.13 | −0.25 | −0.22 | −0.5 |
| Financing | 0 | 0 | 0 | −0.03 | 2.03 | 4.18 | 0.32 | −0.13 | 0.58 | 1.1 | 1.43 | 0.89 |
| Net Cash Flow | 0 | 0 | −0.01 | 0.02 | 0 | 0.67 | −0.04 | −0.18 | −0.26 | −0.13 | 0.18 | 0.2 |
| Free Cash Flow | 0 | 0 | 0 | 0.05 | −2.03 | −3.52 | −0.36 | −0.06 | −1.33 | −1.72 | −1.73 | −0.2 |
| CFO/EBITDA | — | 0 | 17 | 100 | 0 | 2,443 | 82 | 539 | 285 | 297 | 736 | 180 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365 | 219 | 183 | 243 | 134 | 234 | 384 | 212 | 203 | 338 | 272 | 269 |
| Inventory Days | 4,380 | 438 | 1,460 | 2,738 | 6,448 | 701 | 852 | 344 | 215 | 269 | 151 | 152 |
| Days Payable | 1,460 | 292 | 730 | 1,095 | 1,460 | 14.6 | 104 | 20.66 | 61.47 | 207 | 177 | 209 |
| Cash Conversion Cycle | 3,285 | 365 | 913 | 1,886 | 5,122 | 920 | 1,132 | 536 | 356 | 399 | 246 | 212 |
| Working Capital Days | 1,278 | 110 | 287 | 527 | 463 | 4,118 | 9,067 | 2,747 | 1,605 | 1,879 | 951 | 771 |
| ROCE % | 0% | 0% | 0.57% | 0.56% | 9.95% | 0.47% | 0.12% | 2.49% | 0.71% | 0.86% | 1.69% | 1.67% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Novateor Research Laboratories insights
53 extracted metrics across FY15–FY26.
Documents
- General announcements 16 Oct 2026
- General announcements 15 Oct 2026
- General announcements 15 Oct 2026
Frequently Asked Questions about Novateor Research Laboratories
What does Novateor Research Laboratories Ltd do?
Where is Novateor Research Laboratories Ltd (NOVATEOR) listed?
Which sector does Novateor Research Laboratories Ltd belong to?
What is the 52-week high and low of Novateor Research Laboratories Ltd?
What is the Return on Equity (ROE) of Novateor Research Laboratories Ltd?
Company Information
Incorporated in 2011, Novateor Research Laboratories Ltd is in the business of Oral Care and Personal Care products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542771.md for Novateor Research Laboratories Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.